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 Dear Editor,
 We read in a previous issue a letter commenting our 
article “Inappropriate Prescribing to Elderly Patients in an 
Internal Medicine Ward”.1 We welcome the authors for the 
insightful ideas conveyed regarding our recently submitted 
article on deprescribing in an elderly Portuguese popula-
tion.
 There are several tools available to help clinicians with 
medication review and deprescribing such as the Beers 
criteria. However, these do not usually provide a practical 
approach and the majority of the drugs mentioned are not 
currently used. Therefore, in our daily practice, we combine 
the Beers criteria with START and STOP criteria, as well 
as algorithms and guidelines from the Bruyère Research 
Institute (deprescribing.org).2-5 Nonetheless, one of the 
most noticeable pitfalls of the Beers criteria is the fact that 
the avoidance of proton pump inhibitors was only included 
in 2015.
 Although deprescribing.org algorithms, nowadays, 
are limited to five pharmacological classes, they include 
a planned process engaging both patients and caregivers 
and how dose tapering should be done. These guidelines/
algorithms are also graphically easier to read and consult. 
In our paper, cholinesterase inhibitors and memantine were 
not included, as these guidelines were not available at the 
time of submission of our manuscript.6
 There are noticeable differences between our study and 
the one from Dias et al, which also assessed an elderly 
Portuguese population.7 First, we used criteria from depre-
scribing.org, whereas Dias et al used the Beers criteria 
(2012 update); second, we included a total of 483 patients 
aged > 65 years over a period of 7 months (versus 100 
patients over 1 year). These features could at least partially 
explain the lower proportion of inappropriate prescribing at 
discharge in our study (17.2% vs 46%). Both studies were 
performed in a single centre. Larger multicentre studies are 
needed to get a better picture of the appropriate prescrib-
ing/deprescribing scenario in Portugal.
 We believe that Internal Medicine wards need to im-
prove their prescribing/deprescribing at discharge. Drug 
reconciliation should be applied in all contacts with the pa-
tient, whether in the emergency, in-patient or ambulatory 
settings.
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